Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons (Q43543771)

24 November 2017

title

Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons (English)

1 reference

24 November 2017

Ye JH

1

1 reference

24 November 2017

Tao L

series ordinal

2

1 reference

24 November 2017

Zalcman SS

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

894

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

241-248

1 reference

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

A synaptic model of memory: long-term potentiation in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Excitatory amino acid receptors and synaptic plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Recent advances in the understanding of interleukin-2 signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-2 as a neuroregulatory cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

The role of excitatory amino acids in neuropsychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Modulation of neuronal migration by NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

A role for interleukin-2 in the regulation of striatal dopaminergic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Neuronal injury associated with HIV-1: approaches to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Ethanol inhibits NMDA-activated ion current in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Behavioral and Electrocortical Spectrum Power Effects after Microinfusion of Lymphokines in Several Areas of the Rat Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Magnesium gates glutamate-activated channels in mouse central neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Electrophysiological evidence for the existence of NMDA and non‐NMDA receptors on rat ventral tegmental dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Synaptic regulation of mesocorticolimbic dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Brain dopamine and reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Glycine-activated chloride currents of neurons freshly isolated from the ventral tegmental area of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-2 and -6 induce behavioral-activating effects in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902056-X

10.1016/S0006-8993(01)02056-X

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference